1,015 results on '"Pirisi, Mario"'
Search Results
2. THU-486-YI A multi-center comparison of Atezolizumab plus Bevacizumab and Lenvatinib as primary systemic therapy for unresectable hepatocellar carcinoma: focus on thrombotic and hemorragic adverse events
3. FRI-028 Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease of mixed etiology
4. SAT-524 Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study
5. THU-471-YI From randomised clinical trials to clinical practice: a systematic reviewand meta-analysis of real-word data on atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
6. The Potential Role of Vitamin D Supplementation in Cognitive Impairment Prevention
7. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis
8. The Role of New Morphological Parameters Provided by the BC 6800 Plus Analyzer in the Early Diagnosis of Sepsis
9. HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment
10. Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection.
11. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.
12. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19
13. From MASH to HCC: the role of Gas6/TAM receptors
14. Unveiling the Mystery of Adult-Onset Still's Disease: a Compelling Case Report
15. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis
16. High Mobility Group Box-1 as a Candidate Biomarker of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
17. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
18. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study
19. Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study
20. Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
21. Unveiling the Mystery of Adult-Onset Still's Disease: A Compelling Case Report.
22. Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study
23. Circadian control of hepatitis B virus replication
24. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
25. Understanding protection from SARS-CoV-2 using metabolomics
26. The association between education level and chronic liver disease of any etiology
27. Eosinophilic gastroenteritis in pregnancy: A review of the literature
28. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids
29. Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
30. Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis
31. Age related structural and functional changes in left ventricular performance in healthy subjects: a 2D echocardiographic study
32. HepaDisk – A new quality of life questionnaire for HCV patients
33. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)
34. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunctionassociated steatohepatitis.
35. SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
36. Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells
37. Feasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction
38. Tolerability of first line systemic therapy in elderly patients with advanced hepatocellular carcinoma
39. Spleen stiffness measurement predicts decompensation risk in primary biliary cholangitis
40. Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study
41. Novel Calculators for Risk Stratification in Hepatocellular Carcinoma: A Concise Review
42. Role of Vitamin D in Rheumatoid Arthritis
43. First reported human case of meningitis by Staphylococcus condimenti
44. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients
45. Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy
46. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
47. Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
48. Supplementary Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
49. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
50. Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.